Turning Point Therapeutics, Inc. Stock Split Ratio
Turning Point Therapeutics, Inc. had Stock Split Ratio of 25.90% as of 2019-04-05, per its 10-K filed 2020-03-18.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2020-03-18
- 2019-04-05: Stockholders' Equity Note, Stock Split, Conversion Ratio 25.90%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2019-04-05 | 25.90% 10-K · filed 2020-03-18 |